Ticker Details
Monte Rosa Therapeutics, Inc.
IPO Date:	June 24, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.45B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.41 | 4.14%
Avg Daily Range (30 D):	$0.54 | 2.53%
Avg Daily Range (90 D):	$0.59 | 3.68%

Institutional Daily Volume
Avg Daily Volume:	.47M
Avg Daily Volume (30 D):	1.11M
Avg Daily Volume (90 D):	1.22M

Trade Size
Avg Trade Size (Sh.):	89
Avg Trade Size (Sh.) (30 D):	66
Avg Trade Size (Sh.) (90 D):	69

Institutional Trades
Total Institutional Trades:	398
Avg Institutional Trade:	$2.41M
Avg Institutional Trade (30 D):	$2.04M
Avg Institutional Trade (90 D):	$1.96M
Avg Institutional Trade Volume:	.22M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.48M
Avg Closing Trade (30 D):	$2.73M
Avg Closing Trade (90 D):	$2.35M
Avg Closing Volume:	182.18K

News

Feb 6, 2026 @ 5:16 PM 3 High-Risk Stocks That Soared in 2025 But Can Sti... Source: Chris Markoch

Jan 9, 2026 @ 3:49 AM Monte Rosa Therapeutics Announces Pricing of $300 ... Source: Na

Nov 8, 2025 @ 4:30 PM Monte Rosa Therapeutics Presents Preclinical Data ... Source: Monte Rosa Therapeutics

Nov 3, 2025 @ 12:00 PM Monte Rosa Therapeutics to Participate in Upcoming... Source: Monte Rosa Therapeutics

Oct 24, 2025 @ 11:00 AM Monte Rosa Therapeutics Presents Preclinical Data ... Source: Monte Rosa Therapeutics

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS
Diluted EPS
Revenue	$181.54M	$12.77M	$23.19M
Gross Profit
Net Income / Loss	$20.95M	$-27.08M	$-12.3M
Operating Income / Loss	$8.51M	$-32.98M	$-15.55M
Cost of Revenue
Net Cash Flow	$82.81M	$138.91M	$-9.03M
PE Ratio